fludrocortisone has been researched along with androstenedione in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argenziano, A; Di Maio, S; Franzese, A; Gasparini, N; Salerno, M; Tenore, A | 1 |
| Calis, KA; Cho, D; Chrousos, GP; Keil, MF; Merke, DP | 1 |
| Diederich, S; Meyer, B; Oelkers, W; Quinkler, M | 1 |
| Claahsen-van der Grinten, HL; Kapusta, L; Mooij, CF; Otten, BJ | 1 |
| Himes, JH; Lacey, JM; Matern, D; Netzel, BC; Sarafoglou, K; Singh, RJ | 1 |
1 trial(s) available for fludrocortisone and androstenedione
| Article | Year |
|---|---|
Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Diseases; Adult; Aldosterone; Androstenedione; Desoxycorticosterone; Enzyme Inhibitors; Female; Fludrocortisone; Humans; Hydroxysteroid Dehydrogenases; Infusions, Intravenous; Kidney; Male; Middle Aged; Mineralocorticoids; Postmenopause; Potassium; Prednisolone; Prednisone; Progesterone; Sodium; Urodynamics | 2003 |
4 other study(ies) available for fludrocortisone and androstenedione
| Article | Year |
|---|---|
Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Age Determination by Skeleton; Androstenedione; Body Height; Body Weight; Child, Preschool; Cortisone; Female; Fludrocortisone; Growth; Humans; Infant; Male | 1997 |
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; Anti-Inflammatory Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fludrocortisone; Humans; Hydrocortisone; Male; Retreatment; Suspensions; Tablets; Therapeutic Equivalency | 2001 |
Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Alleles; Androstenedione; Anti-Inflammatory Agents; Blood Pressure; DNA; DNA Mutational Analysis; Female; Fludrocortisone; Humans; Infant; Infant, Newborn; Male; Pilot Projects; Renin; Retrospective Studies; Steroid 21-Hydroxylase | 2010 |
Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Androstenedione; Anti-Inflammatory Agents; Blood Specimen Collection; Child; Child, Preschool; Circadian Rhythm; Drug Monitoring; Fludrocortisone; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Reproducibility of Results | 2011 |